0001104659-19-001169.txt : 20190107
0001104659-19-001169.hdr.sgml : 20190107
20190107203451
ACCESSION NUMBER: 0001104659-19-001169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190104
FILED AS OF DATE: 20190107
DATE AS OF CHANGE: 20190107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUYER DAVID R
CENTRAL INDEX KEY: 0001277476
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 19514526
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
4
1
a4.xml
4
X0306
4
2019-01-04
0
0001410939
Ophthotech Corp.
OPHT
0001277476
GUYER DAVID R
C/O OPHTHOTECH CORPORATION
ONE PENN PLAZA, 35TH FLOOR
NEW YORK
NY
10119
1
1
0
0
Executive Chairman
Common Stock
2019-01-04
4
M
0
6250
A
47023
D
Common Stock
2019-01-07
4
S
0
3859
1.30
D
43164
D
Restricted Stock Units
2019-01-04
4
M
0
6250
0.00
D
2026-01-03
Common Stock
6250
6250
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 4, 2019.
On January 4, 2016, the reporting person was granted an award of 25,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan.
/s/ Todd Anderman, as Attorney-in-Fact for David R. Guyer
2019-01-07